Premium
Acute lymphoblastic leukemia relapse after CD19‐targeted chimeric antigen receptor T cell therapy
Author(s) -
Wang Jiasheng,
Hu Yongxian,
Huang He
Publication year - 2017
Publication title -
journal of leukocyte biology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.5ru0817-315r
Subject(s) - chimeric antigen receptor , cd19 , immunogenicity , immunology , bone marrow , leukemia , acute lymphocytic leukemia , biology , lymphoblastic leukemia , antigen , oncology , cancer research , t cell , medicine , immune system
Review of different mechanisms leading to ALL relapse after CAR‐t therapy, and different strategies to minimize the relapse.